Rabies is one of the deadliest infectious diseases, but it is also preventable when treated quickly after an animal bite. A new post-licensure clinical study published in The Lancet further demonstrates that Rabishield, a monoclonal antibody therapy developed by UMass Chan Medical School in partnership with the Serum Institute of India, offers a safe and effective alternative to older rabies treatments.
This article was originally published on MedicalXpress.com